22EL-736 On-Demand eCast: Ethical Issues in Transfusion Medicine, Blood Banking, and Biotherapies

Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP) | 1 Physician (PHY)

Live Program Date: Thursday, May 19, 2022
Program Number: 22EL-736

Educational Track: Technical/Clinical
Topic: Patient Transfusion
Intended Audience: Directors, Hospital Blood Banks, Hospitals, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Perfusionists, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers

Faculty
(titles and affiliations at the time of the live program)
Director/Moderator: Michael Passwater, MT(ASCP)SBB,DLM, Blood Bank Manager, UF Shands Hospital, Gainesville, FL
Speakers: Hilary F. Ryder, MD, MS, FACP, FHM, HEC-C, Clinical Ethicist and Associate Professor of Medicine, Texas Christian University and UNTHSC School of Medicine, Fort Worth, TX; Director of Internal Medicine Education, Texas Health Fort Worth; Justin Kreuter, MD, Consultant and Instructor, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Program Description
Practicing Transfusion Medicine can involve challenging ethical situations because blood is a voluntarily donated precious medical resource with a limited shelf life. Both supply and demand can be uncertain. This program will explore ethical dilemmas such as resource allocation when demand is anticipated to exceed supply, blood refusal, donor incentives, informed consent, and introducing investigational treatments. These topics will be approached from the perspective of both an ethicist and a transfusion medicine specialist, with the goal of applying a practical ethics framework.

Learning Objectives
After participating in this educational activity, participants should be able to:

  • Discuss common ethical issues in the field of Transfusion Medicine today.
  • Discuss common ethical issues in the field of Cellular Therapies/Biotherapies today.
  • Paraphrase how your hospital ethics committee can help you resolve ethical disputes, create ethical policies, and provide ethics education.

How to Claim Continuing Education Credit

  • Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.
  • Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to eLearning@aabb.org within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.

Director & Moderator

Speaker Image for Michael Passwater
Michael Passwater, MT(ASCP)SBB,DLM
UF Shands Hospital

Speakers

Speaker Image for Hilary Ryder
Hilary F. Ryder, MD, MS, FACP, FHM, HEC-C
Texas Christian University and UNTHSC School of Medicine; Texas Health Fort Worth
Speaker Image for Justin Kreuter
Consultant and Instructor, Laboratory Medicine and Pathology, Mayo Clinic

Related Products

Thumbnail for AM24-TU-01-O: Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies (Enduring)
AM24-TU-01-O: Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies (Enduring)
Emerging chimeric antigen receptor (CAR) T cell technology has recently helped transform treatment options for cancer patients…
Thumbnail for AM24-MN-32-O: Lyophilized, Stem-cell Derived, and Synthetic Platelet Products are Closer Than You May Think (Enduring)
AM24-MN-32-O: Lyophilized, Stem-cell Derived, and Synthetic Platelet Products are Closer Than You May Think (Enduring)
This session will highlight advances in three areas of platelet research; stabilization methods through lyophilization, iPSC ex-vivo production, and synthetic nanoparticle technology are converging and can lead to long-lived platelet-based therapies targeted to address specific related pathologies…
Thumbnail for AM24-MN-34-O: Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation (Enduring)
AM24-MN-34-O: Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation (Enduring)
Hematopoietic stem cells (HSCs) are the apex hematopoietic cell with the potential to produce robust and lifelong production of all blood cells. Thus, understanding the details of HSC molecular biology is critical to our understanding of human health and longevity…
Thumbnail for AM24-TU-10-O: Is Your Firm Ready for an FDA Office of Inspections and Investigations Inspection?  Hear about the Most Frequently Cited Observations and Inspectional Process from FDA’s Office of Biologics Inspectorate (Enduring)
AM24-TU-10-O: Is Your Firm Ready for an FDA Office of Inspections and Investigations Inspection? Hear about the Most Frequently Cited Observations and Inspectional Process from FDA’s Office of Biologics Inspectorate (Enduring)
This informative session will give an overview of inspections conducted by FDA’s Office of Inspections and Investigations (OII), Office of Biologics Inspectorate (OBI), including OBI’s role in regulatory inspections and current regulatory oversight…